Shanghai Junshi Biosciences H1 2021 Interim Results Presentation

Shanghai Junshi Biosciences presents interim financial results and operational highlights for the twelve months ended June 30, 2021. The biotech company focuses on developing treatment options that deliver superior efficacy at lower cost to patients.